Every SEC Form 3/4/5 on record for this filer (CIK 1309439) — 2 issuers, 9 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| JBGS | JBG SMITH Properties | Director | 2017-07-20 → 2026-05-01 | 12 | $121,610 |
| STML | STEMLINE THERAPEUTICS INC | Director · lapsed | 2016-05-26 → 2020-06-10 | 7 | $20,020 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| JBGS | 2022-05-10 | Buy | 3,000 | $24.67 | $74,010 | 3,000 |
| JBGS | 2022-05-10 | Buy | 1,000 | $23.75 | $23,750 | 5,000 |
| JBGS | 2022-05-10 | Buy | 1,000 | $23.85 | $23,850 | 4,000 |
| STML | 2019-12-04 | Buy | 1,000 | $9.73 | $9,730 | 88,298 |
| STML | 2019-12-02 | Buy | 1,000 | $10.29 | $10,290 | 87,298 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.
